Cargando…
The efficacy of PD‐1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study
OBJECTIVE: Immune checkpoint inhibitors (ICIs) have been considered as novel therapeutic approaches for various cancers. ICIs were reportedly efficacious against rare cancers, including salivary gland carcinoma (SGC). We aimed to analyze the efficacy and safety of ICIs in patients with SGC. METHODS:...
Autores principales: | Sato, Ryosuke, Kumai, Takumi, Ishida, Yoshiya, Yuasa, Ryota, Kubota, Akinobu, Wakisaka, Risa, Komatsuda, Hiroki, Yamaki, Hidekiyo, Wada, Tetsuji, Harabuchi, Yasuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764769/ https://www.ncbi.nlm.nih.gov/pubmed/36544935 http://dx.doi.org/10.1002/lio2.863 |
Ejemplares similares
-
Antitumor Peptide-Based Vaccine in the Limelight
por: Kumai, Takumi, et al.
Publicado: (2022) -
Intraductal Salivary Gland Infusion With Botulinum Toxin
por: Schwalje, Adam T., et al.
Publicado: (2019) -
IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer
por: Kono, Michihisa, et al.
Publicado: (2022) -
Novel Multidisciplinary Salivary Gland Society (MSGS) Questionnaire: An International Consensus
por: Buchholzer, Samanta, et al.
Publicado: (2021) -
Contrast‐enhanced ultrasonography for the differential diagnosis of pleomorphic adenomas and Warthin tumors in salivary glands
por: Saito, Daisuke, et al.
Publicado: (2021)